Quercetin for Dyskeratosis Congenita
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the safety of quercetin, a vitamin-like substance, for individuals with Dyskeratosis congenita (DC) or telomere biology disorders (TBD). These rare conditions can affect the skin, nails, and blood. Participants will take quercetin orally twice a day. The trial seeks individuals diagnosed with DC or TBD who can take medication by mouth. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new treatment.
Will I have to stop taking my current medications?
You may need to stop taking certain medications. If you are on androgen therapy, digoxin, or fluoroquinolone and cannot stop for medical reasons, you may not be eligible to participate.
Is there any evidence suggesting that quercetin is likely to be safe for humans?
Research has shown that quercetin is generally safe for people. One study found that individuals with conditions similar to Dyskeratosis congenita (DC) tolerated quercetin well at all tested doses. Other studies in adults suggest that taking up to 1,000 mg of quercetin daily for 12 weeks is likely safe. No evidence indicates that quercetin is seriously toxic or causes cancer. While more research is needed for people with DC, these early findings offer some reassurance about quercetin's safety.12345
Why do researchers think this study treatment might be promising?
Unlike the standard treatments for Dyskeratosis Congenita, which often focus on managing symptoms with therapies like androgens, steroids, or bone marrow transplantation, Quercetin offers a novel approach. Quercetin is a plant-derived compound known for its antioxidant properties, which may target the cellular stress and damage linked to this genetic disorder. Researchers are excited about its potential to provide a more direct and less invasive treatment option by addressing underlying cellular issues rather than just alleviating symptoms. This could mean a significant improvement in quality of life for patients with fewer side effects compared to more aggressive treatments.
What evidence suggests that quercetin might be an effective treatment for Dyskeratosis congenita?
Studies have shown that quercetin, a natural compound in many fruits and vegetables, may help with issues related to telomeres. Telomeres are parts of DNA that influence aging and cell health. Research suggests that quercetin can lengthen telomeres, with one study noting a significant increase after supplementation. Quercetin has also been studied for its ability to reduce senescent cells, which are old cells that have stopped dividing and can cause harm. This suggests quercetin might improve cell health. Although limited studies exist on quercetin specifically for Dyskeratosis congenita, a rare condition affecting telomeres, these findings offer a hopeful starting point. Participants in this trial will receive quercetin to evaluate its effects on Dyskeratosis congenita.12367
Who Is on the Research Team?
Parinda Mehta, MD
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Are You a Good Fit for This Trial?
This trial is for people diagnosed with Dyskeratosis congenita (DC) or other telomere biology disorders. Specific inclusion and exclusion criteria are not listed, but participants must have one of these rare conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive quercetin treatment for Dyskeratosis Congenita/Telomere Biology Disorders
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Quercetin
Trial Overview
The study is testing the safety of quercetin, a vitamin-like substance, in individuals with DC or telomere biology disorders. All participants will receive quercetin to see how well it is tolerated.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Quercetin dose (based on patient weight and as a percentage of adult dose - as noted in Table 2) will be given orally on a twice a day schedule starting with weight adjusted maximum total daily dose of 4000 mg/day (and administered in divided doses bid). For patients who weigh 70 kg or more, the starting dose will be automatically assigned at the maximum dose of 4000 mg/day.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
Citations
Quercetin Dyskeratosis Congenita (DC)/Telomere Biology ...
It identifies the role of the intervention that participants receive. Types of arms include experimental arm, active comparator arm, placebo ...
Dyskeratosis Congenita Links Telomere Attrition to Age ... - PMC
Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease ...
3.
ctv.veeva.com
ctv.veeva.com/study/quercetin-dyskeratosis-congenita-dc-telomere-biology-disorders-tbdQuercetin Dyskeratosis Congenita (DC)/Telomere Biology ...
This study will enroll approximately 12 patients with DC/TBD who will be treated with quercetin for 24 weeks.
Quercetin Intake and Absolute Telomere Length in Patients ...
Quercetin supplementation was associated with a significant increase in mean TL (odds ratio ≥ 2.44; p < 0.05) with a strengthened association after full ...
Dyskeratosis congenita: natural history of the disease ...
Six patients died, the median age was 13 years. As of November 2022, eight patients were still alive, with a median age of 18 years [range, 6–32 years].
Risk assessment of quercetin dihydrate and rutin in food ...
In rats, the highest quercetin levels were found in lung, testis and kidney the safety data were not shown. The results of any self-reported ...
Safety Data Sheet: Quercetin
Uses advised against: Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.